3 Penny Stocks to Add to Your Watchlist in March
As March is only a day away, finding penny stocks to buy next month is on many investors minds. With a new month comes a clean slate for investors to find penny stocks that could be worth buying, or those that could be worth avoiding. And with so much going on in the stock market right now, knowing the difference is crucial to making money with penny stocks.
Right now, the main issue as we all know is conflict between Ukraine and Russia. This has continued to wreak havoc on world markets. And with no end in sight, investors should continue to consider how this will affect their portfolios. So, with that in mind, let’s take a look at three penny stocks to add to your watchlist in March 2022.
3 Penny Stocks For Your March 2022 Watchlist
- Zomedica Corp. (NYSE: ZOM)
- Neurosense Therapeutics Ltd. (NASDAQ: NRSN)
- Nordic American Tanker Ltd. (NYSE: NAT)
Zomedica Corp. (NYSE: ZOM)
One of the biggest gainers of the day is ZOM stock. By midday, shares of ZOM had shot up by over 16%. This is a major gain, especially considering the recent bearish momentum that Zomedica has seen. In the past month, shares of ZOM stock have shot up by over 29%. The main reason for its uptick comes as the company announced its Q4 and 2021 full year balance sheet.
In the report, Zomedica announced revenue of $4.1 million with a gross margin of 73.9% for the 2021 year. This is compared to $0 in 2020 and the fourth quarter of the same year. Additionally, Zomedica reported ending the quarter with cash on hand of roughly $195 million. One of its recent acquired companies, PulseVet, also saw its revenue grow during the fourth quarter of 2021 by more than 60% over the previous years same quarter.
“I am excited about our recent progress and looking forward to releasing the full details of our fourth quarter and 2021 performance on March 1st, via our 2021 Form 10-K and accompanying press release, and then discussing it further at the Q1 Virtual Summit on March 8th.”The CEO of Zomedica, Larry Heaton
Over the past few months, we’ve covered ZOM stock numerous times. This is due to its constant mentions online and trending nature. While this report does show that Zomedica is growing, it will take some time before it is able to grow to its full potential. Considering this, is ZOM stock worth adding to your penny stocks watchlist or not?
Neurosense Therapeutics Ltd. (NASDAQ: NRSN)
Another big gainer of the day is NRSN stock. At midday, shares of NRSN stock had shot up by over 36%. This is a major gain and reflects a sizable bullish turnaround from Neurosense’s 48% six month loss. So, why is NRSN stock climbing right now? Well, it’s tough to tell as no-company specific news came out during trading today. However, with above average volume, we can look at recent updates from the company.
The most recent news came on February 24th when it announced that its head of Scientific Programs, Dr. Shiran Zimri, would present at the American Society for Experimental Neurotherapeutics on Thursday, March 3rd. The presentation titled, “Breaking the Paradigm – PrimeC as a Novel Approach to ALS Therapy” willful discuss the companies formulation of two FDA-approved drugs that could hopefully treat ALS.
“Our proprietary combination therapy approach using two well-established drugs to treat a disease as complex as ALS not only breaks the current paradigm of focusing on one target, it also potentially enables a faster path to market.
With a well-established safety profile, the combination therapy’s efficacy is focused on three targets: regulating microRNA synthesis, modulating iron accumulation, and attenuating neuroinflammation, and has achieved meaningful outcomes in clinical and preclinical studies to date.”The Head of Scientific Programs at Neurosense, Dr. Shiran Zimri
This is great news for the company as presentations always help to show what a company is up to and what it is capable of. Considering that it continues to make these big moves, it’s no wonder why so many investors are watching Neurosense. And, with the major emphasis on biotech penny stocks right now, NRSN stock could be worth keeping an eye on. With that in mind, will it be on your penny stocks watchlist?
Nordic American Tanker Ltd. (NYSE: NAT)
With over 20% in gains on February 28th at midday, it’s clear that Nordic American is in focus. And while that may seem like a lot, in the past five days, shares of NAT stock have shot up by over 49%. The big news from the company today came as more purchases of NAT stock were made by board member, Alexander Hansson. Alexander Hansson is the son of the founder, Chairman and CEO of Nordic America.
Today, news came that he purchased 250,000 shares at $2.05 per share. Insider buying is always an interesting prospect for investors to keep note of. And this comes only a week or so after the company reported its fourth-quarter 2021 results. In the results, it posted that the fourth quarter of 2021 was the best it has seen in five quarters. During this time, it was able to increase its average time charter equivalent or TCE to $10,100 per day per ship. This is 74% more than the previous quarter.
In addition, the company brought in a net loss of $21 million, which is nothing to write home about. However, it did substantially lower this over the previous quarter’s net loss of $44.6 million. With two new buildings under constriction right now, the company looks like it is in an advantageous position to keep growing. So, whether this makes NAT worth adding to your list of penny stocks to buy is up to you.
Are Penny Stocks Worth Buying Right Now?
If you’re looking for penny stocks to buy, there are hundreds to choose from. Because of that, it all comes down to understanding where to look to find the best ones, and which are worth it.
With such a wide variety of penny stocks, investors need to have a well-thought-out trading strategy on hand that can adapt to the changing market conditions. So, with this considered, do you think penny stocks are worth buying right now or not?